Free Newsletter
Nanoparticles used to destroy tumors
Researchers expect to advance nanoparticle tumor therapies into the clinic this year, hoping to develop a radical new approach to fighting cancer. Researchers at Rice and the University of Texas Health Science Center have been testing nanoparticles in animal models for several years. Tiny, gold-coated spheres are injected into the blood stream and congregate in the tumors. By shining an infrared light through the skin, the researchers can heat up the nanoparticles inside and destroy the tumor. Complete remission has been achieved in animals. If the same holds true for humans, it would offer a fundamentally new approach to tumor therapy, doing away with chemotherapy that is often attended with harsh side effects.
- read the report on nanoparticles from Technology Review
ALSO: Two University of Kentucky College of Pharmacy researchers have won a patent on a manufacturing process for nanoparticles. Report
Related Articles:
FDA gathers expert advice on bionanotechnology. Report
Nanotech grows more common in drug dev research. Report
Nanodevice used to detect response to therapeutics. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: